Device
Pulmonary vein ablation
Pulmonary vein ablation is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_3
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
Suspended1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (33.3%)
N/A2 (66.7%)
Trials by Status
completed375%
suspended125%
Recent Activity
0 active trials
Showing 4 of 4
completed
Non-invasive Characterization of the Mechanisms of Atrial Fibrillation Maintenance
NCT02497248
completednot_applicable
AF Septal Pacing (Clinical Investigation Plan)
NCT03242941
completednot_applicable
Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrillation
NCT00293943
suspendedphase_3
High Intensity Focused Ultrasound (HIFU) Ablation System Study
NCT00392106
Clinical Trials (4)
Showing 4 of 4 trials
NCT02497248
Non-invasive Characterization of the Mechanisms of Atrial Fibrillation Maintenance
NCT03242941Not Applicable
AF Septal Pacing (Clinical Investigation Plan)
NCT00293943Not Applicable
Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrillation
NCT00392106Phase 3
High Intensity Focused Ultrasound (HIFU) Ablation System Study
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4